Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indo…

Blueprint Medicines, a Sanofi company, today announced AYVAKIT® (avapritinib) data showing clinically meaningful outcomes and ...

McDonald's Big Arch Review: Cast This Burger Into The Fast Food Abyss And Just Order A Big Mac

The Big Arch has finally reached the Golden Arches menu in the U.S. We tried this new burger to see if it's worth the fuss and how it compares to the classics.

Get Ready For The Big Arch: McDonald’s Massive Double-Patty Burger Set For U.S. Launch

McDonald's is poised to roll out its Big Arch burger in the U.S. in March, joining a wave of fast-food chains offering larger sandwiches.

The healthiest tinned tomato soups ranked by a dietitian, from Heinz to supermarket own-brands

More expensive doesn't always mean better for you.
Foodie on MSN

The popular Jersey Mike's sub you may want to avoid ordering

Sub shops and fast food outlets aren't exactly known for being the healthiest choices, but we couldn't believe the nutritional stats for this popular sub.

North America Pasta Market Forecast and Company Analysis Report 2025-2033 Featuring Ebro Foods, General Mills, Campbell Soup, Conagra Foods, Unilever, Treehouse Foods, Nestle ...

The North America pasta market is set for significant growth, rising from $6.48 billion in 2025 to $8.91 billion by 2033, at a CAGR of 4.05%. Key growth drivers include a demand for convenient meal ...
AHA/ASA Journals

Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation

BACKGROUND: Novel treatments are needed for the primary and secondary prevention of heart failure in patients with type 2 diabetes, including individuals with and those without a history of heart ...